BACKGROUND: The Centers for Disease Control and Prevention (CDC) initiated the Colorectal Cancer Screening Demonstration Program (CRCSDP) in 2005 to explore the feasibility of establishing a colorectal cancer screening program for underserved US populations. We provide a detailed overview of the evaluation and an assessment of the costs incurred during the service delivery (screening) phase of the program. METHODS: Tailored cost questionnaires were completed by staff at the five CRCSDP sites for the first 2 years of the program. We collected cost data for clinical and programmatic activities (program management, data collection and tracking, etc.). We also measured in-kind contributions and assigned values to them. RESULTS: During the first 2 years of the demonstration excluding the start-up cost, the average cost per person was $2569. Per person cost of clinical services alone ranged from $264 to $1385, while per person programmatic costs ranged from $545 to $3017. CONCLUSION: Colorectal cancer screening programs can incur substantial costs for some non-clinical activities, such as data collection/tracking, and these support activities should be managed carefully to control costs and ensure successful program implementation. Our findings highlight the importance of performing economic evaluation to guide the design of future colorectal cancer screening programs.
BACKGROUND: The Centers for Disease Control and Prevention (CDC) initiated the Colorectal Cancer Screening Demonstration Program (CRCSDP) in 2005 to explore the feasibility of establishing a colorectal cancer screening program for underserved US populations. We provide a detailed overview of the evaluation and an assessment of the costs incurred during the service delivery (screening) phase of the program. METHODS: Tailored cost questionnaires were completed by staff at the five CRCSDP sites for the first 2 years of the program. We collected cost data for clinical and programmatic activities (program management, data collection and tracking, etc.). We also measured in-kind contributions and assigned values to them. RESULTS: During the first 2 years of the demonstration excluding the start-up cost, the average cost per person was $2569. Per person cost of clinical services alone ranged from $264 to $1385, while per person programmatic costs ranged from $545 to $3017. CONCLUSION:Colorectal cancer screening programs can incur substantial costs for some non-clinical activities, such as data collection/tracking, and these support activities should be managed carefully to control costs and ensure successful program implementation. Our findings highlight the importance of performing economic evaluation to guide the design of future colorectal cancer screening programs.
Authors: Uri Ladabaum; Ajitha Mannalithara; Reinier G S Meester; Samir Gupta; Robert E Schoen Journal: Gastroenterology Date: 2019-03-28 Impact factor: 22.682
Authors: Sujha Subramanian; Florence K L Tangka; Sonja Hoover; Marion Nadel; Robert Smith; Wendy Atkin; Julietta Patnick Journal: J Public Health Manag Pract Date: 2016 Sep-Oct
Authors: Ma Somsouk; Carly Rachocki; Ajitha Mannalithara; Dianne Garcia; Victoria Laleau; Barbara Grimes; Rachel B Issaka; Ellen Chen; Eric Vittinghoff; Jean A Shapiro; Uri Ladabaum Journal: J Natl Cancer Inst Date: 2020-03-01 Impact factor: 13.506
Authors: Simon L Goede; Karen M Kuntz; Marjolein van Ballegooijen; Amy B Knudsen; Iris Lansdorp-Vogelaar; Florence K Tangka; David H Howard; Joseph Chin; Ann G Zauber; Laura C Seeff Journal: Med Care Date: 2015-07 Impact factor: 2.983
Authors: Karen E Kim; Fornessa Randal; Matt Johnson; Michael Quinn; Chieko Maene; Sonja Hoover; Valerie Richmond-Reese; Florence K L Tangka; Djenaba A Joseph; Sujha Subramanian Journal: Cancer Date: 2018-10-25 Impact factor: 6.860
Authors: Florence K L Tangka; Sujha Subramanian; Sonja Hoover; Amy DeGroff; Djenaba Joseph; Faye L Wong; Lisa C Richardson Journal: Health Promot Pract Date: 2020-09-29